Abstract

The Fibromyalgia is considered the second most common rheumatic disorder, with prevalence between 2% to 8% of the population, depending on the diagnostic criteria that are used. Symptoms are diverse and include a history of headaches, generalized pain, dysmenorrhea, chronic fatigue, irritable bowel syndrome and functional gastrointestinal disorders, among others. Thus, a state of centralized pain, where a lifelong disorder with early onset, can trigger pain experienced in different regions of the body and at different moments, being amplified divide to an alteration of the pain threshold. The photosonic treatment, which enables the combined action of physiotherapeutic resources, is based on the normalization of the pain threshold with the central nervous system. Were evaluated 51 patients who underwent photosonic treatment in periods after treatment of 120 days and 300 days, evaluating the Fibromyalgia Impact Questionnaire and the Visual Analogue Scale. Continuity of improvement was observed in relation to the Fibromyalgia Impact Questionnaire and the Visual Analogue Scale, in relation to the periods of 120 days and 300 days after treatment, significantly. The long-term efficacy observed in the present study shows the efficiency of photonic treatment and the recommendation of a periodicity tends to be beneficial for the maintenance of the physiological state obtained.

Keywords: Fibromyalgia; Fotobiomodulation; Therapeutic ultrasound; Photosonic treatment